RecruitingNot Applicable

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

Turkey (Türkiye)100 participantsStarted 2024-09-10

Plain-language summary

Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that the ilioinguinal and iliohypogastric nerves contribute mostly.With transversus abdominis plane block(TAPB),it is planned to provide analgesia by creating a block in these nerve branches that contribute to the sensory innervation of the intervention area.In addition;it was aimed to investigate patient's and physician's satisfaction during the procedure.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient is over 18 years of age * Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient, * The above-mentioned procedures will be taken under elective conditions, * Providing an optimal image when imaging the patient with ultrasound, * INR\< 1.5 * If the patient gives consent, S/he will be included in the study. Exclusion Criteria: * Patients under 18 years of age, * Patients treated under emergency conditions, * morbid obesity (BMI\>35 kg/m2), * pregnant women, * New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure, * Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure, * Patients with a history of allergy to local anesthetics, * Patients who cannot be communicated, * Those with severe psychosis or progressive neurological deficits and muscle disease, * Patients who do not consent to the application will be excluded from the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

measuring the analgesic efficacy of TAPB

Timeframe: 4 months

For patient and physician satisfaction;5-point Likert scale will be used. Minimum satisfaction score is one point, maksimum satisfaction score is five points.Higher scores have positive outcomes.

Timeframe: 4 months

Trial details

NCT IDNCT06576128

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-15

Contact for this trial

Gozde Altun

+905544290333 gozde.altun@iuc.edu.tr

View on ClinicalTrials.gov More Anesthesiology trials